📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An open-label trial of JAK 1/2 blockade in progressive IFIH1 -associated neuroinflammation (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1212/wnl.0000000000004921

PubMed Identifier: 29321238

Publication URI: http://europepmc.org/abstract/MED/29321238

Type: Journal Article/Review

Parent Publication: Neurology

Issue: 6

ISSN: 0028-3878